22,036 Shares in Danaher Corporation $DHR Purchased by Citizens Financial Group Inc. RI

Citizens Financial Group Inc. RI purchased a new stake in Danaher Corporation (NYSE:DHRFree Report) during the second quarter, HoldingsChannel.com reports. The firm purchased 22,036 shares of the conglomerate’s stock, valued at approximately $4,197,000.

Other large investors have also recently bought and sold shares of the company. High Note Wealth LLC boosted its holdings in shares of Danaher by 19.2% during the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock worth $67,000 after acquiring an additional 47 shares during the period. First Command Advisory Services Inc. grew its position in shares of Danaher by 4.4% in the fourth quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock valued at $253,000 after purchasing an additional 47 shares during the last quarter. GW&K Investment Management LLC increased its stake in shares of Danaher by 8.4% during the fourth quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock worth $138,000 after purchasing an additional 47 shares during the period. Kestra Private Wealth Services LLC lifted its holdings in Danaher by 0.3% during the 3rd quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock worth $3,057,000 after purchasing an additional 48 shares during the last quarter. Finally, SOL Capital Management CO boosted its stake in Danaher by 2.7% in the 4th quarter. SOL Capital Management CO now owns 1,879 shares of the conglomerate’s stock valued at $430,000 after purchasing an additional 50 shares during the period. 79.05% of the stock is owned by institutional investors.

Danaher Price Performance

Shares of NYSE DHR opened at $199.62 on Wednesday. The business has a fifty day moving average price of $193.74 and a two-hundred day moving average price of $192.50. The stock has a market capitalization of $140.33 billion, a PE ratio of 35.46, a P/E/G ratio of 2.52 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80.

Danaher (NYSE:DHRGet Free Report) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same period in the prior year, the firm posted $0.77 EPS. Danaher’s quarterly revenue was up 5.5% on a year-over-year basis. As a group, equities analysts predict that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have commented on the company. JPMorgan Chase & Co. decreased their price objective on Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Wells Fargo & Company reduced their target price on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 22nd. Morgan Stanley decreased their price target on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. DZ Bank started coverage on shares of Danaher in a research report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price target on the stock. Finally, Weiss Ratings upgraded shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $228.91.

Check Out Our Latest Research Report on Danaher

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

See Also

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.